Compare TransMedics Group Inc (TMDX) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? TransMedics Group Inc trades at $87.67 (market cap $3.10B), while Consumer Staples Select Sector SPDR Fund trades at $84.93. The key difference: Consumer Staples Select Sector SPDR Fund is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | XLP | |
|---|---|---|
Market Cap | $3.10B | — |
Sector | Technology | — |
52-Week High | $150.42 | $90.00 |
52-Week Low | $61.99 | $75.61 |
Enterprise Value | $3.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.
Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.
XLP, the Consumer Staples Select Sector SPDR ETF, trades at $84.585, down 0.43% today. Technical indicators show a neutral overall signal with bullish moving averages, while oscillators remain neutral. The ETF's 2.6% dividend yield provides income appeal, with a dividend scheduled for payment on June 24, 2026. Recent news highlights consumer staples as a defensive play amid market rotation, with Coca-Cola's strong Q2 2026 earnings underscoring sector resilience (ETF Trends, July 29, 2026).
Outlook remains positive given 100% analyst buy ratings and defensive positioning during economic uncertainty. Key risks include sector concentration and sensitivity to consumer spending shifts. The ETF's stability and income generation support a favorable risk-reward profile for conservative investors seeking exposure to essential consumer goods.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
